Ensuring safe and effective drugs: who can do what it takes?

被引：32

作者：

Jefferson, Tom ^{[2
]}

Doshi, Peter ^{[1
]}

Thompson, Matthew ^{[3
,4
]}

Heneghan, Carl ^{[3
]}

机构：

[1] MIT, Program Hist Anthropol Sci Technol & Soc, Cambridge, MA 02139 USA

[2] Cochrane Collaborat, Acute Resp Infect Grp, Rome, Italy

[3] Univ Oxford, Dept Primary Hlth Care, Oxford, England

[4] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 342卷

关键词：

ACUTE INFLUENZA; OSELTAMIVIR; EFFICACY; ROSIGLITAZONE;

D O I：

10.1136/bmj.c7258

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：148 / 151

页数：4

共 20 条

[1]

[Anonymous], ROSIGLITAZONE CRITIC

[2]

[Anonymous], NEUR INH INFL HTA

[3] Drug Regulation Rosiglitazone: what went wrong? [J].

Cohen, Deborah .

BRITISH MEDICAL JOURNAL, 2010, 341 :530-535

[4] Complications: tracking down the data on oseltamivir [J].

Cohen, Deborah .

BMJ-BRITISH MEDICAL JOURNAL, 2009, 339

[5] Neuraminidase inhibitors-the story behind the Cochrane review [J].

Doshi, Peter .

BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :1348-1351

[6] We want raw data, now [J].

Godlee, Fiona .

BRITISH MEDICAL JOURNAL, 2009, 339

[7]

Higgins J., 2008, Cochrane Handbook for Systematic Reviews of Interventions, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]

[8] The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence [J].

Ioannidis, John P. A. ;

Karassa, Fotini B. .

BRITISH MEDICAL JOURNAL, 2010, 341 :762-765

[9] Antivirals for influenza in healthy adults: systematic review [J].

Jefferson, T ;

Demicheli, V ;

Rivetti, D ;

Jones, M ;

Di Pietrantonj, C ;

Rivetti, A .

LANCET, 2006, 367 (9507) :303-313

[10] Neuraminidase inhibitors for preventing and treating influenza in healthy adults [J].

Jefferson, T. O. ;

Demicheli, V ;

Di Pietrantonj, C. ;

Jones, M. ;

Rivetti, D. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03)

← 1 2 →